Bridging traditional knowledge and modern technology: In-silico ethnopharmacology in herbal drug discovery
Authors: Redhu, Archana Kumari; Thaker, Kavita; Singh, Priyanka; Mehta, Raj; Kodolikar, Kshitij; Chandrani, Pratik; Gundeti, Manohar; Gota, Vikram
Source journal: Journal of Ayurveda and integrative medicine (2026-11-16)
DOI: 10.1016/j.jaim.2026.101442
Abstract
The use of herbal medicines and phytochemicals has gained considerable attention due to their structural diversity, selective toxicity, lower incidence of adverse effects, and affordability compared to conventional chemotherapy. Nevertheless, their precise mechanisms of action and bioactive constituents remain insufficiently understood, limiting their clinical translation and highlighting the need for rigorous scientific investigation. This review provides an integrative perspective on herbal-based drug discovery, beginning with the intersection of traditional disease classification systems, such as Ayurveda, and modern frameworks such as the International Classification of Diseases (ICD), enabling the alignment of ethnomedical knowledge with contemporary biomedical standards. Relevant literature available up to May 2026 was identified through searches of PubMed, Web of Science, Scopus, ScienceDirect, and Google Scholar using keywords related to ethnopharmacology, phytochemicals, and computational drug discovery, with emphasis on recent advances while retaining key seminal studies. The review examines the application of network pharmacology and systems biology in elucidating the multi-target and multi-pathway actions of herbal medicines. Computational approaches, including virtual screening, molecular docking, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling, are discussed for their roles in identifying and prioritizing bioactive phytochemicals. The utility of herbal databases, together with forward and reverse docking, Lipinski-based filtering, and drug repurposing strategies, is highlighted. Key challenges, including protein flexibility, phytochemical variability, and limited experimental validation, are critically evaluated. Emerging approaches integrating multi-omics technologies, CRISPR-based functional studies, and high-throughput sequencing are also discussed as future directions for accelerating herbal drug discovery. Therefore, rather than replacing experimental or clinical validation, these computational approaches primarily serve as hypothesis-generating tools that require further preclinical and clinical investigation.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.